# RedHill Biopharma Ltd. — Form D

RedHill Biopharma Ltd. of TEL AVIV, L3, a company, filed a Form D exempt-offering notice with the SEC on 2023-08-07. The offering totals $2.7M, of which $2.7M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2023-08-07
- Form: D
- Accession: 0001178913-23-002730
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $2.7M
- Amount sold: $2.7M
- Investors: 1
- Date of first sale: 2023-07-21
- Security types: equity
- Revenue range: $25,000,001 - $100,000,000
- SEC file number: 021-488980

## Issuer

- Name: RedHill Biopharma Ltd.
- CIK: 0001553846
- Entity type: Corporation
- Jurisdiction: ISRAEL
- Incorporated: 2009
- Address: 21 HA'ARBA'A STREET, TEL AVIV, L3, 6473921
- Phone: 972-3-541-3131

## Officers, directors & promoters (33)

_Showing 25 of 33 people._

| Name | Role | Location |
| --- | --- | --- |
| Eric Swenden | Director | Tel Aviv, L3 |
| Kenneth Reed | Director | Waltham, MA |
| Dror Ben-Asher | Director | Tel Aviv, L3 |
| Dror Ben-Asher | Executive Officer | Tel Aviv, L3 |
| Guy Goldberg | Executive Officer | Tel Aviv, L3 |
| Reza Fathi | Executive Officer | Tel Aviv, L3 |
| Alla Felder | Director | Tel Aviv, L3 |
| Gilead Raday | Executive Officer | Tel Aviv, L3 |
| Ofer Tsimchi | Director | Tel Aviv, L3 |
| Shmuel Cabilly | Director | Tel Aviv, L3 |
| Razi Ingber | Executive Officer | Tel Aviv, L3 |
| Adi Frish | Executive Officer | Tel Aviv, L3 |
| Rick Scruggs | Director | Tel Aviv, L3 |
| Rick Scruggs | Executive Officer | Tel Aviv, L3 |
| Micha Ben Chorin | Executive Officer | Tel Aviv, L3 |
| June Almenoff | Executive Officer | Tel Aviv, L3 |
| June D Almenoff | Executive Officer | TEL AVIV, L3 |
| Rick D Scruggs | Director | TEL AVIV, L3 |
| Rick D Scruggs | Executive Officer | TEL AVIV, L3 |
| Nicolas D Weinstein | Director | TEL AVIV, L3 |
| Alla D Felder | Director | TEL AVIV, L3 |
| Micha D Ben Chorin | Executive Officer | TEL AVIV, L3 |
| Adi D Frish | Executive Officer | TEL AVIV, L3 |
| Gilead D Raday | Executive Officer | TEL AVIV, L3 |
| Guy D Goldberg | Executive Officer | TEL AVIV, L3 |

## Other filings by this issuer (5)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2024-02-05](https://search.stillhousedata.com/formd/0001178913-24-000357) | D | $10.0M | $10.0M |
| [2023-10-12](https://search.stillhousedata.com/formd/0001178913-23-003313) | D | $4.0M | $4.0M |
| [2021-11-22](https://search.stillhousedata.com/formd/0001178913-21-003671) | D | $10.0M | $5.0M |
| [2019-11-06](https://search.stillhousedata.com/formd/0001553846-19-000003) | D | $48.3M | $48.3M |
| [2014-01-15](https://search.stillhousedata.com/formd/0001144204-14-002372) | D | $2.5M | $2.5M |

## More

- [CIK 1553846 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1553846&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001178913-23-002730.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.